Author: Staff
-
Adjusting to New Norms: Interest Rates and Affordability Reshape the Canadian Housing Market
The Canadian housing market is facing a multifaceted set of challenges that have seen a significant impact on pricing, sales activity, and overall market health. A report from Century 21 Canada highlighted that the country experienced a slight drop in prices due to the Bank of Canada’s interest rate hikes, aimed at fighting inflation. Big…
-
Revive Therapeutics (RVV.C) licenses patent on long COVID biomarkers
Revive Therapeutics (RVV.C), a company that specializes in creating treatments and tests for diseases that don’t have many existing options available, has made a deal with a health research group called Lawson Health Research Institute to license the rights to use special signals in the blood—called biomarkers—that can show if someone has ‘long COVID.’ “We…
-
Tempus Resources (TMRR.V) rolls grenade into the room and leaves the country
Just days after Tempus Resources (TMRR.V, though not for much longer) dropped a middling resource update and ‘big news’ that they were extending the option on a lithium property, CEO Jason Bahnsen has announced not only is he not closing that deal after all, but his company is abandoning the Canadian markets altogether and disappearing…
-
Top 5 stock gainers and losers: BIG.V, POND.V, BABY.TO
In this summary report, we will take a quick look at the top 5 gainers and losers up or down double digits on the Canadian stock markets. Here is a summary of the intraday action of assets: Top 5 Gainers Else Nutrition Holdings (BABY.TO) Market Cap ~ $38 million Else Nutrition Holdings Inc. engages in…
-
Ashley Gold (ASHL.C) CEO is tired of waiting around, wants drills in the ground
Conventional wisdom in the junior mining world is, if your stock price isn’t ramping up, and the market isn’t giving love to anyone, the one thing to do in a hurry is wait. Just.. wait. Pay yourself of course, because you’re not a charity. And maybe put out a news release about some conference you’re…
-
Private med reformulator SecureDose acquired by PharmaDrug Inc (PHRX.C)
A few weeks back, in what has become a seminal Equity.Guru piece about the quickly legalizing safe supply drug space, I tore into PharmaDrug (PHRX.C), which was lurching into strategic alternatives land as it appeared to have run out of dough to push its drug trials forward. Pharmadrug (PHRX.C) would love to be in the cocaine…
-
Revive Therapeutics (RVV.C): Covid came, Covid went, but Revive is still fighting
Back at the dawn of Covid-19, a load of public companies started pumping out news releases that claimed they were going to be entering the medical space. In the best tradition of Howe Street, long dormant mining companies suddenly became med-tech deals, hawking everything from clear plastic checkout counter dividers to virus sniffing doorways to…
-
Niocorp Developments (NB.T) gaps keep filling as stock runs hard
UPDATE: Niocorp has ripped a further $1+ since this article was posted, now sitting at $7 and showing the first signs of profit taking. We talked up Niocorp Developments (NB.T) eighteen months ago as a rare earths explorer with an elite project, advancing quickly, and rolling into a rich SPAC. It looked pretty darn tasty.…